Award Data

The Development and Evaluation of of Video Based Directly Observed Therapy for Office Based Treatment of Opioid Use Disorders with Buprenorphine is a project to develop a sustainable scalable and patient centered mobile health mHealth platform comprised of a patient facing mobile application and provider facing web portal for opioid use disorder treatment Methadone clinics are based on a directly ...

PROJECT SUMMARYemocha Mobile HealthInc and Johns Hopkins investigators have developed a userfriendlyHIPAA compliant application for asynchronous video directly observed therapyDOTmiDOTThe miDOT platform consists of a patientfacing mobile application where patients can recordvideos of themselves taking medication at their convenience and a providerfacing web portalthat allows providers to monitor a ...

Project Summary Outcomes following solid organ transplantationSOTare generally excellent withyear survival exceedingfor most graft types and age groupsImmunosuppression nonadherence is an important factor leading to graft failure and patient mortality in SOT recipients since individuals are required to make a lifelong commitment to a strict medication scheduleNonadherence has been reported to rang ...

Project Summary Outcomes following solid organ transplantation (SOT) are generally excellent with 5-year survival exceeding 85% for most graft types and age groups. Immunosuppression nonadherence is an important factor leading to graft failure and patient mortality in SOT recipients since individuals are required to make a lifelong commitment to a strict medication schedule. Nonadherence has been ...

PROJECT SUMMARY Methadone remains a cornerstone of treatment for opioid use disorders (OUD). Daily or frequent supervised treatment with visual confirmation of ingestion (directly-observed therapy or “DOT”), is the standard of care for methadone treatment in federally licensed opioid treatment programs (OTPs) in the United States. DOT ensures adherence and mitigates the risk of medication pois ...

DESCRIPTION (provided by applicant): Case Western Reserve University researchers and BioInVision, Inc. will develop a cryo-imaging system for 3D imaging of mice. It will serve applications in stem cell regenerative medicine, metastatic cancer, and pathogen/immune system response, among others. By alternately sectioning and imaging, the system will enable one to acquire 3D high-resolution color and ...

DESCRIPTION (provided by applicant): BioInVision, Inc. and Case Western Reserve University researchers will develop a cryo-imaging system for 3D imaging of mice. It will serve very many applications in biological research and the biotechnology industry, in cluding mouse anatomical phenotyping, drug delivery, imaging agents, metastastic cancer, pathogen/immune system response, and stem cells/regene ...

DESCRIPTION (provided by applicant): Cryo-imaging, as developed by BioInVision, Inc., and fluorescent reporter gene transgenic mice will be used to determine even subtle or rare developmental abnormalities resulting from toxic exposures. By alternately sec- tioning and imaging, the cryo-imaging system will acquire 3D, high-resolution anatomical color and cellular fluorescence images. The cryo-imag ...

DESCRIPTION (provided by applicant): The capacity to evaluate the teratoma forming potential of differentiated embryonic stem cell populations represents an urgent need before widespread therapeutic application of these cells is possible. Researchers at Case Western Reserve University and BioInVision, Inc. will join together to create platform technologies for validating existing embryonic stem ce ...

DESCRIPTION (provided by applicant): Case Western Reserve University researchers and BioInVision, Inc. will develop a cryo-imaging system for 3D imaging of mice. It will serve applications in stem cell regenerative medicine, metastatic cancer, and pathogen/immune system response, among others. By alternately sectioning and imaging, the system will enable one to acquire 3D high-resolution color and ...